SEC Form 10-Q Summary
Filing identity: The provided filing is for Agrify Corporation (NASDAQ: AGFY), not RYTHM, Inc. Investors should verify the issuer before relying on this summary.
Business Context and Reporting Period
Agrify provides cultivation, extraction, facility build-out, software, and related equipment solutions for the cannabis and indoor agriculture industries. The unaudited report covers the three months ended March 31, 2024, compared with the three months ended March 31, 2023. The company is a smaller reporting company, emerging growth company, and non-accelerated filer.
Financial Performance and Position
| Metric | Q1 2024 | Q1 2023 | Change |
|---|---|---|---|
| Revenue | $2.598 million | $5.804 million | Down 55% |
| Gross profit | $0.729 million | $0.988 million | Down 26% |
| Gross margin | 28.1% | Approximately 17.0% | Improved |
| Operating loss | $0.780 million | $7.584 million | Improved |
| Net loss | $0.038 million | $10.327 million | Improved |
| Operating cash flow | $(2.987) million | $(9.469) million | Improved |
| Cash and marketable securities | Approximately $0.1 million | Not clearly stated in the filing summary | Materially limited liquidity |
- Extraction solutions generated $2.450 million of Q1 revenue, compared with $4.978 million in the prior-year quarter. Cultivation solutions revenue was $0.086 million, Agrify Insights software revenue was $0.062 million, and facility build-out revenue was zero.
- Cost of goods sold declined 61% to $1.869 million. Management reported a 33% gross margin on extraction solutions and an approximately negative 169% margin on cultivation-related revenue.
- Operating expenses declined to $1.509 million from $8.572 million, primarily due to lower general and administrative, selling and marketing, and research and development spending, together with a $2.180 million reduction in contingent consideration.
- Other income included an $0.873 million gain from the change in fair value of warrant liabilities. Q1 2023 included a $4.620 million loss on extinguishment of long-term debt.
- Total assets were $40.861 million and total liabilities were $50.586 million at March 31, 2024. Agrify reported stockholders’ deficit of $9.955 million attributable to Agrify.
- Total debt was $24.264 million, including approximately $21.194 million classified as long-term. Future debt payments disclosed were $2.487 million during the remainder of 2024 and $21.778 million in 2025.
- Accounts receivable were $0.211 million net of a $2.512 million allowance. Net loan receivables were $11.583 million after an $18.885 million allowance. Inventory was $18.862 million net of $17.184 million in reserves.
Material Changes Versus the Prior Comparable Period
- Revenue declined $3.206 million, primarily because of lower extraction revenue and the discontinuation of facility build-outs under the TTK Solutions program.
- Cost reductions substantially narrowed the operating and net losses, but the company remained cash-flow negative and dependent on external financing.
- On January 25, 2024, debt was consolidated into a related-party senior secured note with approximately $18.7 million of principal at issuance, a 10% interest rate, and a December 31, 2025 maturity. Approximately $3.9 million was immediately converted into 2,671,633 common shares.
- On February 27–28, 2024, Agrify completed a public offering of common stock and pre-funded warrants, generating approximately $2.2 million of net proceeds. The offering materially increased shares outstanding and potential dilution.
- Warrant liabilities declined from $1.290 million at December 31, 2023 to $0.417 million at March 31, 2024, producing a non-cash gain of $0.873 million.
- In February 2024, Agrify satisfied conditions under a Mack Molding settlement, recognized gains of approximately $1.142 million and $0.564 million, and reclassified approximately $4.838 million of obligations into notes payable.
Guidance, Outlook, Risks, and Unusual Items
- Management expects full-year gross margins in the mid-teens, aided by extraction equipment sales. It expects meaningful software and production-fee revenue from TTK Solutions to begin in late Q3 or early Q4 2024.
- Management expects continued investment in VFUs, Agrify Insights software, and extraction products, while continuing headcount and operating-cost reductions.
- The financial statements state that substantial doubt exists regarding the company’s ability to continue as a going concern. Agrify had only approximately $0.1 million of cash, cash equivalents, and marketable securities against $27.740 million of current liabilities at March 31, 2024. Management expects to seek additional debt or equity financing for 2024 and 2025.
- Agrify remained subject to Nasdaq deficiencies relating to stockholders’ equity and minimum bid price. The equity-compliance exception was extended to May 15, 2024, and the minimum bid-price compliance period was scheduled to expire September 3, 2024. Delisting could impair liquidity, financing access, and share price.
- Disclosure controls and procedures were not effective as of March 31, 2024 because of previously identified material weaknesses in internal control over financial reporting.
- Material legal matters include Bud & Mary’s litigation involving a fully reserved $14.7 million loan receivable, Bowdoin-related claims of approximately $6.3 million, a separate Hannon Electric claim for approximately $1.498 million, TRC claims of approximately $0.565 million, and McCutchan litigation seeking no less than $3 million.
- The company disclosed substantial customer and collection risk: two customers represented approximately 47% of accounts receivable, and the company was pursuing approximately $2.5 million of receivables through 10 separate legal proceedings.
- In April 2024, a holder exercised 953,684 pre-funded warrants for common stock. The filing also references April 2024 term sheets involving Nature’s Miracle Holding Inc.; the provided text does not establish the final terms or completion of any related transaction.
Most Important Facts for Investors to Verify
- Confirm that Agrify Corporation, rather than RYTHM, Inc., is the intended issuer and filing.
- Verify the company’s post-quarter Nasdaq listing status, including compliance with the stockholders’ equity and minimum bid-price requirements.
- Assess near-term liquidity and whether additional financing was obtained after March 31, 2024.
- Review the terms, collateral, covenants, conversion provisions, and related-party status of the approximately $17.683 million consolidated CP Acquisitions note.
- Evaluate dilution from the February offering, warrant exercises, convertible debt, outstanding warrants, and related-party conversions.
- Review the going-concern disclosure and whether management’s planned cost reductions and financing activities are sufficient to fund operations through the next twelve months.
- Examine the collectability of loan receivables, customer receivables, and the outcomes of the disclosed litigation and settlement obligations.
- Reconcile management’s gross-margin discussion with the filing’s inconsistent wording regarding the prior-year gross margin.